Correlation Between SavvyLong NVDA and Modus Therapeutics
Can any of the company-specific risk be diversified away by investing in both SavvyLong NVDA and Modus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SavvyLong NVDA and Modus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SavvyLong NVDA ETF and Modus Therapeutics Holding, you can compare the effects of market volatilities on SavvyLong NVDA and Modus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SavvyLong NVDA with a short position of Modus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SavvyLong NVDA and Modus Therapeutics.
Diversification Opportunities for SavvyLong NVDA and Modus Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SavvyLong and Modus is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding SavvyLong NVDA ETF and Modus Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Modus Therapeutics and SavvyLong NVDA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SavvyLong NVDA ETF are associated (or correlated) with Modus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Modus Therapeutics has no effect on the direction of SavvyLong NVDA i.e., SavvyLong NVDA and Modus Therapeutics go up and down completely randomly.
Pair Corralation between SavvyLong NVDA and Modus Therapeutics
Assuming the 90 days trading horizon SavvyLong NVDA ETF is expected to generate 0.49 times more return on investment than Modus Therapeutics. However, SavvyLong NVDA ETF is 2.04 times less risky than Modus Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Modus Therapeutics Holding is currently generating about -0.26 per unit of risk. If you would invest 3,282 in SavvyLong NVDA ETF on August 27, 2025 and sell it today you would lose (85.00) from holding SavvyLong NVDA ETF or give up 2.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 96.88% |
| Values | Daily Returns |
SavvyLong NVDA ETF vs. Modus Therapeutics Holding
Performance |
| Timeline |
| SavvyLong NVDA ETF |
| Modus Therapeutics |
SavvyLong NVDA and Modus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SavvyLong NVDA and Modus Therapeutics
The main advantage of trading using opposite SavvyLong NVDA and Modus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SavvyLong NVDA position performs unexpectedly, Modus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Modus Therapeutics will offset losses from the drop in Modus Therapeutics' long position.| SavvyLong NVDA vs. SavvyLong AMZN ETF | SavvyLong NVDA vs. SavvyLong TSLA ETF | SavvyLong NVDA vs. SavvyLong MSFT ETF | SavvyLong NVDA vs. SavvyLong Geared Crude |
| Modus Therapeutics vs. Invisio Communications AB | Modus Therapeutics vs. Svenska Handelsbanken AB | Modus Therapeutics vs. Skandinaviska Enskilda Banken | Modus Therapeutics vs. Nordic Asia Investment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets |